Schedule 13D ownership disclosure

LANTERN PHARMA INC

Security class unavailable · CUSIP: 51654W101

Event date: 2023-11-29

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
Unavailable
Percent of class
3.5000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001104659-23-122546
Form type
SC 13D/A
Filer
Bios Equity Partners, LP
CIK
CIK 1813314
Filed
Dec 01, 2023
Reporting period
Nov 29, 2023
Description
Schedule 13D beneficial ownership

Explore SEC Filings Hub